Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000643610 | SCV000765297 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Ai |
RCV002223237 | SCV002501069 | uncertain significance | not provided | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002223237 | SCV002541991 | uncertain significance | not provided | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477426 | SCV002779806 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002223237 | SCV004148212 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TTN: PM2, PP3 |